Beneficial ownership — 13D / 13G
87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | URGN UroGen Pharma Ltd. | 13G | 9.99% | Dec 19, 2023 | 2y |
| Erik M. Herzfeld, et al. | HERZ Herzfeld Credit Income Fund, Inc | 13D/A | 19.86% | Dec 18, 2023 | 2y |
| Thomas J. Herzfeld, et al. | HERZ Herzfeld Credit Income Fund, Inc | 13D/A | 27.08% | Dec 18, 2023 | 2y |
| Vereniging AEGON | AEG Aegon Ltd. | 13D/A | 18% | Dec 8, 2023 | 2y |
| F. Hurst Lin (“Lin”) | AUGX Augmedix, Inc. Common Stock | 13D/A | 9.1% | Nov 20, 2023 | 2y |
| CSS LLC/IL | SPE Special Opportunities Fund, Inc. | 13G | 5.67% | Oct 30, 2023 | 2y |
| Galloway Capital Partners, LLC | RGS Regis Corp | 13D | 4.9% | Dec 28, 2023 | 2y |
| GILEAD SCIENCES, INC. | ACLX Arcellx, Inc. | 13G/A | 12.9% | Dec 28, 2023 | 2y |
| SIT INVESTMENT ASSOCIATES INC | KTF Dws Municipal Income Trust | 13D/A | 13.58% | Dec 28, 2023 | 2y |
| Point72 Hong Kong Ltd | HUYA HUYA Inc. | 13G | 5% | Dec 27, 2023 | 2y |
| Point72 Asset Management, L.P. | PAGS PagSeguro Digital Ltd. | 13G | 5.1% | Dec 27, 2023 | 2y |
| Redmile Group, LLC | FATE Fate Therapeutics Inc | 13D/A | 14.9% | Dec 26, 2023 | 2y |
| MORGAN STANLEY | EMBJ Embraer S.A. | 13G | 5% | Dec 26, 2023 | 2y |
| Clarence E. Smith | PKTX ProtoKinetix, Inc. | 13D/A | 28.4% | Dec 26, 2023 | 2y |
| GLOBAL VALUE INVESTMENT CORP. | FLNT Fluent, Inc. | 13D/A | 6.23% | Dec 26, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | KALV KalVista Pharmaceuticals, Inc. | 13G/A | 10.3% | Dec 26, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | THRX Theseus Pharmaceuticals, Inc. Common Stock | 13D/A | 7.3% | Dec 22, 2023 | 2y |
| Cavalry Fund I LP | BDRX Biodexa Pharmaceuticals Plc | 13G | 9.9% | Dec 21, 2023 | 2y |
| Noll Shaun | DRTTF Dirtt Environmental Solutions Ltd | 13D/A | 35.9% | Dec 21, 2023 | 2y |
| Frank B. Holding, Jr. | FCNCA First Citizens Bancshares Inc | 13D/A | 16.8% | Dec 19, 2023 | 2y |
| VITO GARFI | SQFT Presidio Property Trust, Inc. | 13D | 3.7% | Dec 19, 2023 | 2y |
| City of Hope | SRT Startek Inc. | 13G | 7.2% | Dec 19, 2023 | 2y |
| Jeffrey Eugene Guida | MSAI MultiSensor AI Holdings, Inc. | 13D | 6.2% | Dec 19, 2023 | 2y |
| HG Vora Capital Management, LLC | PENN PENN Entertainment, Inc. | 13D | 9.6% | Dec 18, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | OCUL Ocular Therapeutix, Inc | 13G | 6.8% | Dec 18, 2023 | 2y |
| MCI Capital, LC | SRT Startek Inc. | 13D/A | 7.56% | Dec 18, 2023 | 2y |
| Phoenix Financial Ltd. | KMDA Kamada Ltd | 13G/A | 7.51% | Dec 18, 2023 | 2y |
| Altos Venture AG | ONCO Onconetix, Inc. | 13G | 5% | Dec 15, 2023 | 2y |
| Sea Otter Advisors LLC | BLEU bleuacacia ltd Class A Ordinary Shares | 13G/A | 0% | Dec 15, 2023 | 2y |
| Mordechai Rapaport | TOFB Tofutti Brands Inc | 13G | 5.03% | Dec 15, 2023 | 2y |
| Regal Nutra LLC | CAUD Collective Audience, Inc.. Common Stock | 13G | 5.3% | Dec 7, 2023 | 2y |
| Sea Otter Advisors LLC | MBTC Nocturne Acquisition Corporation Ordinary Shares | 13G/A | 0% | Dec 1, 2023 | 2y |
| Sea Otter Advisors LLC | GCTS GCT Semiconductor Holding, Inc. | 13G | 9.51% | Nov 1, 2023 | 2y |
| Sea Otter Advisors LLC | ZEO Zeo Energy Corp. | 13G/A | 0% | Oct 18, 2023 | 2y |
| Sea Otter Advisors LLC | CNDA Concord Acquisition Corp II | 13G/A | 0% | Sep 8, 2023 | 2y |
| CYVN Investments RSC Ltd | NIO NIO Inc. | 13D/A | 21.7% | Dec 27, 2023 | 2y |
| GAMCO INVESTORS, INC. ET AL | CUTR Cutera, Inc. | 13D/A | 4.49% | Dec 26, 2023 | 2y |
| Jacobsen Per A. | BLIN Bridgeline Digital, Inc. | 13G/A | 6.8% | Dec 26, 2023 | 2y |
| KING LUTHER CAPITAL MANAGEMENT CORP | DSGR Distribution Solutions Group, Inc. | 13D/A | 77.6% | Dec 26, 2023 | 2y |
| Charles W. Ergen | DISH DISH Network Corp. | 13D/A | 51.4% | Dec 22, 2023 | 2y |
| ORBIMED ADVISORS LLC | THRX Theseus Pharmaceuticals, Inc. Common Stock | 13D/A | 40.1% | Dec 22, 2023 | 2y |
| Saba Capital Management, L.P. | EMO ClearBridge Energy Midstream Opportunity Fund Inc. | 13D/A | 23.52% | Dec 22, 2023 | 2y |
| Charles W. Ergen | ECHO EchoStar CORP | 13D/A | 59.7% | Dec 22, 2023 | 2y |
| Allan C. Silber | PNT POINT Biopharma Global Inc. Common Stock | 13D/A | 0% | Dec 22, 2023 | 2y |
| Kenneth G. Langone | UFI Unifi Inc | 13D/A | 13.7% | Dec 22, 2023 | 2y |
| INCLUSIVE CAPITAL PARTNERS, L.P. | UFI Unifi Inc | 13D/A | 1.9% | Dec 22, 2023 | 2y |
| Martin P. Sutter | MDXG Mimedx Group, Inc. | 13D/A | 19.3% | Dec 22, 2023 | 2y |
| Paul Marciano | GES Guess, Inc. | 13D/A | 36.7% | Dec 21, 2023 | 2y |
| Maurice Marciano | GES Guess, Inc. | 13D/A | 21.4% | Dec 21, 2023 | 2y |
| White Hat Capital Partners LP | LUNA Luna Innovations Incorporated | 13D | 9.99% | Dec 21, 2023 | 2y |